NITI Aayog

May Not Be New Wave Yet, Vaccination and COVID Protocol Must: Scientists

Covaxin Exits ‘Clinical Trial Mode’, Centre Says

Govt Committee Wants Tiny Buffer Zone for National Park for ‘Holistic Development’

Panel on COVID-19 May Recommend Companies Use CSR Funds To Vaccinate Staff

Govt Doctors Association in Karnataka Demands Choice Between Vaccines

Vaccines Safe, Only 0.18% Adverse Events: Govt

The Elaborate Administration Helming India’s COVID-19 Vaccination Programme